The sector will reach $6.27 billion by 2028 at a CAGR of 9.1%

DUBLIN, January 22, 2023 /PRNewswire/ — The “Global Viscosity Additive Market Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com supply.

Research and Markets Logo

The global viscosupplementation market is expected to reach 6.27 billion US dollars by 2028, according to the publisher. Osteoarthritis patients have a minimally invasive therapeutic option called viscosupplementation.

During viscosupplementation, hyaluronic acid is pushed into the joints. The synovial fluid that covers the joints contains hyaluronic acid, a substance that occurs naturally. It lubricates the joints to allow the bones to move freely and reduce discomfort. Hyaluronic acid levels in the joints are lower in those with osteoarthritis, which causes pain.

According to the research findings, the global Viscosupplementation market was 3.71 billion US dollars in 2022

The global viscosupplementation market to grow at a CAGR of 9.14% during the forecast period:

Increasing incidence of osteoarthritis, increasing geriatric population, and increasing number of product launches and product approvals are the major factors driving the growth of the global viscosupplementation market size. One of the most common types of arthritis is osteoarthritis.

In 2019, the Centers for Disease Control and Prevention estimated that 32.5 million Americans (1 in 7 adults) had osteoarthritis. Due to the rise of chronic diseases such as obesity, diabetes and heart disease, the prevalence of osteoarthritis has reached alarming levels. In addition, lack of physical activity such as exercise is increasing the demand for the treatment of knee and hip osteoarthritis and driving the market expansion.

The single-injection viscosupplement holds the lion’s share

By procedure, the viscosity additive market is divided into three segments, viz. single-injection viscosupplementation, three-injection viscosupplementation and five-injection viscosupplementation. Among all, Single Injection dominates the current viscosupplementation market. Demand for outpatient offices that offer same-day surgical care, including preventive (surgical) and diagnostic procedures, is driving the single-injection segment. Furthermore, increasing product launches and focus on the development of single injections for the treatment of osteoarthritis are expected to contribute to the significant growth of the single injections market during the forecast period.

By Application: Knee osteoarthritis segment dominates the market share

Owing to the increased prevalence of knee osteoarthritis and the growing geriatric population that is more vulnerable to knee osteoarthritis, the knee osteoarthritis segment dominates the Viscosupplementation market and is expected to maintain this trend over the forecast period. In addition, the effect of aging, which reduces the amount of water in cartilage and further reduces its ability to absorb shocks and cushions, makes the older population more susceptible to developing knee osteoarthritis.

The Orthopedic Clinics/Ambulatory Surgery Centers segment is growing at a significant growth rate

By end users, the viscosupplementation market is segmented into hospitals and orthopedic clinics/ambulatory surgery centers. Ambulatory service sites, particularly those that provide outpatient surgery and in-office treatment, have become fierce competitors to hospitals due to the recent adoption of value-based care. Orthopedic clinics/ambulatory surgery centers offer both practical and financial benefits, such as faster access to patients, more affordable prices, more opportunities for physician involvement and outpatient facilities. Thus, they gain a dominant market share in the Viscosupplementation market.

By region: North America and Asia and the Pacific has a significant market share

North America occupies a dominant position in the global viscosity additives market. Factors contributing to the growth of the viscous additive in the North American region are increased prevalence of osteoarthritis and related diseases, aging population, well-established healthcare system, and increasing desire for non-surgical procedures. Furthermore, Asia and the Pacific is expected to grow at a notable growth rate during the forecast period owing to increasing geriatric population and increasing healthcare expenditure.

Market segmentation

Product

1. Single injection of viscosity additive
2. Three injections of Viscosupplementation
3. Five injections of Viscosupplementation

Application

1. Osteoarthritis of the knee
2. Osteoarthritis of the hip joint
3. Osteoarthritis of the hand/wrist
4. Osteoarthritis of the ankle/foot
5. Others

End user

1. Hospitals
2. Orthopedic Clinics/Ambulatory Surgery Centers

Region

1. North America
2. Europe
3. Asia and the Pacific
4. The rest of the world

Key players

1. Anika Therapeutics Inc.
2. Sanofi
3. Zimmer Biomet
4. Smith & Nephew PLC
5. Lifecore Biomedical
6. LG Life Sciences Ltd.
7. F.Hoffmann-La Roche Ltd.
8. Chugai Pharmaceutical Co.

Main topics covered:

1. Introduction

2. Research and methodology

3. Summary

4. Market dynamics

5. Global Viscosupplementation Market

6. Market Share – Global Viscous Additive Analysis

7. Product – Global Viscosupplementation Market

8. Appendix – Global Viscosity Additive Market

9. End User – Global Viscosity Additive Market

10. Region – Global Viscosity Additive Market

11. Company analysis

For more information on this report, visit https://www.researchandmarkets.com/r/nx5odw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Media contact:

Research and Markets
Laura WoodSenior Manager
[email protected]

For EST hours Call +1-917-300-0470
For USA/Canada Call Toll Free +1-800-526-8630
For GMT business hours Call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside USA): +353-1-481-1716

Sission

Sission

See original content: https://www.prnewswire.com/news-releases/global-viscosupplementation-market-report-2022-sector-to-reach-6-27-billion-by-2028-at-a-9- 1-cagr-301727320.html

SOURCE Research and Markets

Leave a Comment

Your email address will not be published. Required fields are marked *